Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
暂无分享,去创建一个
G. Van den Berghe | G. V. Berghe | A. Iranmanesh | R. Baxter | R. Bouillon | J. Veldhuis | P. Wouters | F. Weekers
[1] W. Crowley,et al. Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. , 2000, The Journal of clinical endocrinology and metabolism.
[2] B. Mizock. Metabolic derangements in sepsis and septic shock. , 2000, Critical care clinics.
[3] C. Durbin,et al. Oxford Textbook of Critical Care , 2000 .
[4] G. Van den Berghe,et al. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. , 2000, The Journal of clinical endocrinology and metabolism.
[5] D. McArthur,et al. Multiple Organ Failure , 2000, Springer New York.
[6] D. Papanicolaou,et al. Dose-dependent effects of recombinant human interleukin-6 on the pituitary-testicular axis. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[7] A. Iranmanesh,et al. Two-week pulsatile gonadotropin releasing hormone infusion unmasks dual (hypothalamic and Leydig cell) defects in the healthy aging male gonadotropic axis. , 1999, European journal of endocrinology.
[8] G. Van den Berghe,et al. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. , 1999, The Journal of clinical endocrinology and metabolism.
[9] G. Van den Berghe,et al. Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms. , 1998, The Journal of clinical endocrinology and metabolism.
[10] G. Chrousos,et al. The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription. , 1998, The Journal of clinical endocrinology and metabolism.
[11] G. Van den Berghe,et al. Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. , 1998, The Journal of clinical endocrinology and metabolism.
[12] D. Fryburg,et al. Short-term modulation of the androgen milieu alters pulsatile, but not exercise- or growth hormone (GH)-releasing hormone-stimulated GH secretion in healthy men: impact of gonadal steroid and GH secretory changes on metabolic outcomes. , 1997, The Journal of clinical endocrinology and metabolism.
[13] G. Van den Berghe,et al. Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone‐secretagogues , 1997, Clinical endocrinology.
[14] S. Teitelbaum,et al. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. , 1997, The Journal of clinical investigation.
[15] A. Iranmanesh,et al. Comparison of pulsatile luteinizing hormone secretion between prepubertal children and young adults: evidence for a mass/amplitude-dependent difference without gender or day/night contrasts. , 1997, The Journal of clinical endocrinology and metabolism.
[16] A. Iranmanesh,et al. Pulsatile intravenous gonadotropin-releasing hormone administration averts fasting-induced hypogonadotropism and hypoandrogenemia in healthy, normal weight men. , 1997, The Journal of clinical endocrinology and metabolism.
[17] R. Baxter,et al. Insulin‐like growth factor‐binding protein‐2 in patients with prostate carcinoma and benign prostatic hyperplasia , 1997, Clinical endocrinology.
[18] G. Van den Berghe,et al. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. , 1997, The Journal of clinical endocrinology and metabolism.
[19] G. Van den Berghe,et al. Anterior pituitary function during critical illness and dopamine treatment. , 1996, Critical care medicine.
[20] A. Iranmanesh,et al. Amplified nocturnal luteinizing hormone (LH) secretory burst frequency with selective attenuation of pulsatile (but not basal) testosterone secretion in healthy aged men: possible Leydig cell desensitization to endogenous LH signaling--a clinical research center study. , 1995, The Journal of clinical endocrinology and metabolism.
[21] B A Mizock,et al. Alterations in carbohydrate metabolism during stress: a review of the literature. , 1995, The American journal of medicine.
[22] K. Schärer,et al. Changes in the kinetics and biopotency of luteinizing hormone in hemodialyzed men during treatment with recombinant human erythropoietin. , 1994, Journal of the American Society of Nephrology : JASN.
[23] F. Zegher,et al. Luteinizing hormone secretion and hypoandrogenaemia in critically ill men: effect of dopamine , 1994, Clinical endocrinology.
[24] A. Iranmanesh,et al. Neuroendocrine alterations in the somatotropic and lactotropic axes in uremic men. , 1994, European journal of endocrinology.
[25] J. Saez. Leydig cells: endocrine, paracrine, and autocrine regulation. , 1994, Endocrine reviews.
[26] J. Luton,et al. Evidence of oestradiol-induced changes in gonadotrophin secretion in men with feminizing Leydig cell tumours. , 1994, European journal of endocrinology.
[27] P. Caron,et al. Luteinizing hormone secretory pattern before and after removal of Leydig cell tumor of the testis. , 1994, European journal of endocrinology.
[28] W J Bremner,et al. The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol. , 1994, Journal of andrology.
[29] D. Vanderschueren,et al. Time-related increase of biochemical markers of bone turnover in androgen-deficient male rats. , 1994, Bone and mineral.
[30] J. Orav,et al. Reproductive axis suppression in acute illness is related to disease severity. , 1993, The Journal of clinical endocrinology and metabolism.
[31] A. Iranmanesh,et al. Evidence for attenuation of hypothalamic gonadotropin-releasing hormone (GnRH) impulse strength with preservation of GnRH pulse frequency in men with chronic renal failure. , 1993, The Journal of clinical endocrinology and metabolism.
[32] A. Iranmanesh,et al. Evidence for attenuation of hypothalamic GnRH impulse strength with preservation of GnRH pulse frequency in men with chronic renal failure , 1993 .
[33] C. Longcope,et al. Both hyper- and hypogonadotropic hypogonadism occur transiently in acute illness: bio- and immunoactive gonadotropins. , 1992, The Journal of clinical endocrinology and metabolism.
[34] D. Vanderschueren,et al. Homologous radioimmunoassay of human osteocalcin. , 1992, Clinical chemistry.
[35] A. Iranmanesh,et al. Attenuation of luteinizing hormone secretory burst amplitude as a proximate basis for the hypoandrogenism of healthy aging in men. , 1992, The Journal of clinical endocrinology and metabolism.
[36] V. Kerlan,et al. Oestrogen secreting Leydig cell tumour and GnRH agonist in‐vivo and in‐vitro studies , 1992, Clinical endocrinology.
[37] M L Johnson,et al. Deconvolution analysis of hormone data. , 1992, Methods in enzymology.
[38] W. Crowley,et al. Sex steroid control of gonadotropin secretion in the human male. II. Effects of estradiol administration in normal and gonadotropin-releasing hormone-deficient men. , 1991, The Journal of clinical endocrinology and metabolism.
[39] J. Saez,et al. Growth hormone and insulin-like growth factor I treatment increase testicular luteinizing hormone receptors and steroidogenic responsiveness of growth hormone deficient dwarf mice. , 1991, Endocrinology.
[40] S M Pincus,et al. Approximate entropy as a measure of system complexity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[41] G. Stein,et al. Relationship of cell growth to the regulation of tissue‐specific gene expression during osteoblast differentiation , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[42] R. Baxter,et al. Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex. , 1990, The Journal of clinical endocrinology and metabolism.
[43] R. Bouillon,et al. Immunoradiometric assay of parathyrin with polyclonal and monoclonal region-specific antibodies. , 1990, Clinical chemistry.
[44] M. Giusti,et al. Effect of pulsatile luteinizing hormone — releasing hormone administration on pituitary — gonadal function in elderly man , 1990, Journal of endocrinological investigation.
[45] M. Dufau,et al. Attenuated release of biologically active luteinizing hormone in healthy aging men. , 1988, The Journal of clinical investigation.
[46] K. Menon,et al. The effect of insulin on aromatase activity in isolated human endometrial glands and stroma. , 1987, American journal of obstetrics and gynecology.
[47] C. Cowell,et al. Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma. , 1987, The Journal of clinical endocrinology and metabolism.
[48] R. Baxter,et al. Two immunoreactive binding proteins for insulin-like growth factors in human amniotic fluid: relationship to fetal maturity. , 1987, The Journal of clinical endocrinology and metabolism.
[49] M. Dufau,et al. Estradiol modulates the pulsatile secretion of biologically active luteinizing hormone in man. , 1987, The Journal of clinical investigation.
[50] R. Baxter,et al. Short-term exposure to insulin-like growth factors stimulates testosterone production by testicular interstitial cells. , 1987, Acta endocrinologica.
[51] J. Marshall,et al. Diurnal patterns of pulsatile luteinizing hormone secretion in hypothalamic amenorrhea: reproducibility and responses to opiate blockade and an alpha 2-adrenergic agonist. , 1987, The Journal of clinical endocrinology and metabolism.
[52] N. Christeff,et al. Endotoxin-induced changes in sex steroid hormone levels in male rats. , 1987, Journal of steroid biochemistry.
[53] J. Kaufman,et al. Influence of age on pulsatile luteinizing hormone release and responsiveness of the gonadotrophs to sex hormone feedback in men. , 1987, The Journal of clinical endocrinology and metabolism.
[54] R. Baxter,et al. Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma. , 1986, The Journal of clinical investigation.
[55] W. Vale,et al. Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor. , 1986, Science.
[56] S. Winters,et al. Evidence for a role of endogenous estrogen in the hypothalamic control of gonadotropin secretion in men. , 1985, The Journal of clinical endocrinology and metabolism.
[57] E. Draper,et al. APACHE II: A severity of disease classification system , 1985, Critical care medicine.
[58] A. Rogol,et al. Pathophysiology of male hypogonadism associated with endogenous hyperestrogenism. Evidence for dual defects in the gonadal axis. , 1985, The New England journal of medicine.
[59] R. Hamill,et al. Transient hypogonadotropic hypogonadism caused by critical illness. , 1985, The Journal of clinical endocrinology and metabolism.
[60] C. Grossman. Interactions between the gonadal steroids and the immune system. , 1985, Science.
[61] Kinney Jm,et al. Protein metabolism in the traumatized patient. , 1985 .
[62] W. Crowley,et al. The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. , 1985, Recent progress in hormone research.
[63] J. Kinney,et al. Protein metabolism in the traumatized patient. , 1985, Acta chirurgica Scandinavica. Supplementum.
[64] A. Rogol,et al. Role of endogenous opiates in the expression of negative feedback actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in man. , 1984, The Journal of clinical investigation.
[65] E. Folkerd,et al. The action of dexamethasone and prolactin on aromatase activity in human adipose tissue. , 1984, Journal of steroid biochemistry.
[66] P. Schuetz,et al. Nutritional Support , 2018, The EBMT Handbook.
[67] P. D. de Moor,et al. Androgen and progestogen production in cultured interstitial cells derived from immature rat testis. , 1982, Journal of steroid biochemistry.
[68] C. Mendelson,et al. Estrogen formation in stromal cells of adipose tissue of women: induction by glucocorticosteroids. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[69] J. Wilson,et al. The use and misuse of androgens. , 1980, Metabolism: clinical and experimental.
[70] I. Mowszowicz,et al. On the role of dihydrotestosterone in regulating luteinizing hormone secretion in man. , 1980, The Journal of clinical endocrinology and metabolism.
[71] P. Moor,et al. Stimulation effect of neurotransmitters on the aromatization of testosterone by Sertoli cell-enriched cultures , 1979, Molecular and Cellular Endocrinology.
[72] B Eiseman,et al. Multiple organ failure. , 1977, Surgery, gynecology & obstetrics.
[73] P. D. de Moor,et al. Measurement of 25-hydroxyvitamin D3 in serum. , 1976, Clinical chemistry.
[74] R. Santen. Is aromatization of testosterone to estradiol required for inhibition of luteinizing hormone secretion in men? , 1976, The Journal of clinical investigation.
[75] K. Ryan,et al. Aromatization of androgens by human abdominal and breast fat tissue. , 1975, The Journal of clinical endocrinology and metabolism.
[76] D. Loriaux,et al. Studies of the role of sex steroids in the feedback control of FSH concentrations in men. , 1973, The Journal of clinical endocrinology and metabolism.
[77] D. Adams,et al. Thyroid-stimulating hormone. , 1960, British medical bulletin.